Clarity Pharmaceuticals Ltd (CU6) — Long-term Investment Intensity
Clarity Pharmaceuticals Ltd (CU6) has a Long-term Investment Intensity of 0.0% as of June 2025. Long-term investments of AU$13.53K represent 0.0% of total assets of AU$101.17 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. For the complete balance sheet picture, see balance sheet size of Clarity Pharmaceuticals Ltd.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Clarity Pharmaceuticals Ltd Long-term Investment Intensity (2022–2025)
This chart shows how Clarity Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the intensity stands at 0.0%, reflecting long-term investments of AU$13.53K against total assets of AU$101.17 Million AUD. See Clarity Pharmaceuticals Ltd short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Long-term Investment Intensity for Clarity Pharmaceuticals Ltd (2022–2025)
The table below presents the year-by-year Long-term Investment Intensity for Clarity Pharmaceuticals Ltd from 2022 to 2025, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read CU6 total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (AUD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.0% | AU$13.53K | AU$101.17 Million | ▲ +0.0 pp |
| 2024 | 0.0% | AU$13.03K | AU$154.63 Million | ▼ 0.0 pp |
| 2023 | 0.0% | AU$12.34K | AU$76.90 Million | ▲ +0.0 pp |
| 2022 | 0.0% | AU$11.74K | AU$99.82 Million | — |